Researchers are exploring the role of metabolic processes in the tumor microenvironment and their impact on immunotherapy efficacy. Studies are investigating how tumor-derived metabolites and metabolic reprogramming can influence immune evasion in cancer, with potential implications for therapeutic approaches. The interplay between metabolic adaptations and immune responses in cancer is being examined from various angles, including the effects of dietary factors and the mechanisms of immunosuppressive cells.